1. Diphenyleneiodonium inhibits the activation of mitogen-activated protein kinases and the expression of monocyte chemoattractant protein-1 in Helicobacter pylori-infected gastric epithelial AGS cells.
- Author
-
Cho SO, Lim JW, Kim KH, and Kim H
- Subjects
- Cell Line, Cytokines metabolism, Dose-Response Relationship, Drug, Enzyme Activation, Humans, Inflammation, Korea, NADPH Oxidases antagonists & inhibitors, NADPH Oxidases metabolism, Onium Compounds pharmacology, Reactive Oxygen Species, Chemokine CCL2 metabolism, Epithelial Cells cytology, Gastric Mucosa metabolism, Helicobacter pylori metabolism, MAP Kinase Signaling System
- Abstract
Objective: To investigate whether NADPH oxidase induces MCP-1 expression and the activation of mitogen-activated protein kinases (MAPKs) in H. pylori-infected gastric epithelial cells., Material: H. pylori in Korean isolates, human gastric epithelial AGS cells, Treatment: AGS cells pretreated with or without an NADPH oxidase inhibitor diphenyleneiodonium (DPI) are cultured in the presence of H. pylori at a bacterium/cell ratio of 300:1., Methods: Reactive oxygen species (ROS) and MCP-1 were determined by confocal microscopy and enzyme-linked immonosorbent assay. NADPH oxidase activity was measured by lucigenin assay. mRNA expression of MCP-1 was analyzed by reverse transcription-polymerase chain reaction. Levels of MAPKs were assessed by Western blot analysis., Results: H. pylori induced increase in ROS, NADPH oxidase activity, MCP-1 expression, and the activation of MAPKs including extracellular signal-regulated kinases, p38, and jun N-terminal kinases in AGS cells, which was inhibited by DPI., Conclusion: Inhibiting NADPH oxidase by DPI suppresses H. pylori-induced activation of MAPKs and MCP-1 expression in AGS cells.
- Published
- 2011
- Full Text
- View/download PDF